Advancing Cancer Research with Quantitative Live Cell Imaging
Cancer is a leading human disease with persistently high mortality rates. Thus, understanding the how, where, why and with whom metastatic cancer cells disseminate and proliferate is one of the highest importance in cancer research. The HoloMonitor live cell imaging system advances your cancer research with a non-invasive way to measure and quantify cell activity in real-time without compromising the integrity of your precious cells. Therefore, you can get more accurate and native results from your experiments.
A live cell analysis tool with real-time data
Find out more about how HoloMonitor live cell imaging can accelerate your cancer research!
Featured publications within cancer research
Measure mitotic activity in melanocytes
Cutaneous melanoma is deadly skin cancer. The activating mutation BARFV600E mutation exists both in moles and over half cutaneous melanomas.
In this study, in order to investigate why the same mutation has such different consequences in moles and melanomas, the authors using HoloMonitor studied cell proliferation, cell dry mass, cell death and cell growth rate. The experiments showed by increasing the levels of two microRNAs in melanocytes induces mitotic failure, genome duplication, and proliferation arrest. BRAFV600E induces a similar proliferation arrest in primary human melanocytes that is both reversible and conditional depending on the differentiation state of the melanocyte.
On-demand webinar
The secrets to truly controlled cell experiments for cancer research
Discover HoloMonitor Live Cell Assays
Learn more about what you can do with HoloMonitor
Answer cancer research questions with quantitative live cell imaging
Browsing publications in cancer research
Get inspired by other research fellows, and learn how HoloMonitor quantitative live cell imaging can benefit your cancer research:
Shikonin as a WT1 Inhibitor Promotes Promyeloid Leukemia Cell Differentiation
Journal: Molecules (2022)
Research Areas: Cancer research
Cell Lines: HL-60
Cell migration is impaired in XPA-deficient cells
Journal: FASEB BioAdvances (2022)
Research Areas: Cancer research
Cell Lines: Primary fibroblasts
CAT3, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O6-methylguanine DNA methyltransferase expression
Journal: OncoTargets and Therapy (2022)
Research Areas: Cancer research
Cell Lines: T98G, U251
Genetic deletion of HPV E7 oncogene effectively regresses HPV driven oral squamous carcinoma tumour growth
Journal: Biomedicine & Pharmacotherapy (2022)
Research Areas: Virus, Cancer research
Cell Lines: SCC2, HEK293T cells
The TIGD5 gene located in 8q24 and frequently amplified in ovarian cancers is a tumor suppressor
Journal: Genes to Cells (2022)
Research Areas: Cancer research
Cell Lines: SNU8, SNU119, SKOV3, OVCAR3, K119, HAC2
Jejuketomycins A and B, polyketide glycosides with cancer cell migration inhibitory activity from Streptomyces sp. KCB15JA15
Journal: RSC Advances (2022)
Research Areas: Cancer research
Cell Lines: PC12, HeLa, A549, MEF, MDA-MB-231